Healthcare executive passes out at Oval Office during announcement on weight loss drugs

Healthcare Executive Passes Out During Oval Office Announcement

Gordon Findlay, the Healthcare Executive of Novo Nordisk, fainted during a White House event on weight loss drugs Thursday at the Oval Office.

Incident Details

The announcement, focused on GLP-1 weight loss drugs, was temporarily paused when Findlay lost consciousness. President Donald Trump and Dr. Mehmet Oz immediately turned their attention to him.

"During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted," said White House Press Secretary Karoline Leavitt. "The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”

Event Context

On the same day, President Trump announced a new agreement with Eli Lilly and Novo Nordisk to offer certain obesity medications to Americans at about $150 per month.

This incident briefly interrupted the announcement but did not delay the overall proceedings significantly.

Author’s Summary

The sudden fainting of a Novo Nordisk executive momentarily disrupted a White House press event on weight loss drugs but was quickly managed, allowing the conference to continue.

more

KOMO KOMO — 2025-11-06

More News